The FAST strategy is mainly implemented at specialized and general hospitals with TB units. With support from the USAID TB CARE II Project, the Vietnam NTP developed the “Guideline for FAST strategy implementation”. According to the Guideline, implementing facilities should immediately order GeneXpert MTB/RIF tests for eligible patients including: Pulmonary TB patients AFB(+), presumptive drug-resistant TB patients, presumptive TB among HIV positive people, children with presumptive TB or TB meningitis.
Featured - Home Page
Tumpa, a 14 year old high school student, was diagnosed with TB on March 27, 2011. Although she started taking TB medication the day after, she experienced treatment failure after three months of treatment and was diagnosed with Multi Drug Resistance Tuberculosis (MDR-TB). With her new diagnosis, Tumpa started to take her medication for MDR-TB in August of that year. However, after completing 16 months of treatment, her sputum culture and follow up result remained positive. She was then diagnosed with extensively drug-resistant TB (XDR-TB) in November 2012.
Watch the video in the link below for an overview on TB CARE II through out the past six years.
A new technology entitled GeneXpert was deemed a ‘game-changer’ in the world of TB diagnostics. To reduce the burden and mortality of TB, it is imperative to not only have advanced technologies to detect TB bacteria, but to also have experts that know how to use the new technology. In 2016, USAID TB CARE II funded the attendance of 11 people from select low or middle‐income countries to attend the McGill Summer Institute in Infectious Diseases and Global Health to take courses on Advanced TB Diagnostic Research.
In 2014, approximately 480,000 people developed MDR-TB. 3.3% of new cases and 20% of previously treated patients develop MDR-TB. It was estimated that only 41% of cases were notified that they had MDR-TB in 2014. In low and middle income countries, access to quality TB services is often limited. Since the beginning of TB CARE II in 2010, TB CARE II has worked to decrease MDR-TB.
On October 10-11, 2016, delegates from twenty, primarily low- and middle-income countries gathered at the Council for Scientific and Industrial Research (CSIR) conference center in Pretoria, South Africa.
In 2015, USAID TB CARE II project began an initiative to address TB in miners in the Southern African Region. The overall objective is to improve detection and management of TB and other co-morbidities among the mine workers and their families. This would also help to control the spread of TB and reduce new incidences of TB.
TB CARE II recently hosted a technical meeting on TB infection control in September 2016 in Hanoi, Vietnam.
TB CAREII Bangladesh: TB In Children